IBDEI043 ; ; 12-JAN-2012
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JAN 12, 2012
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5219,2)
 ;;=^267128
 ;;^UTILITY(U,$J,358.3,5220,0)
 ;;=208.90^^50^363^22
 ;;^UTILITY(U,$J,358.3,5220,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5220,1,1,0)
 ;;=1^208.90
 ;;^UTILITY(U,$J,358.3,5220,1,2,0)
 ;;=2^LEUKEMIA,UNSP CELL TYPE
 ;;^UTILITY(U,$J,358.3,5220,2)
 ;;=^336874
 ;;^UTILITY(U,$J,358.3,5221,0)
 ;;=140.9^^50^363^23
 ;;^UTILITY(U,$J,358.3,5221,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5221,1,1,0)
 ;;=1^140.9
 ;;^UTILITY(U,$J,358.3,5221,1,2,0)
 ;;=2^LIP CANCER
 ;;^UTILITY(U,$J,358.3,5221,2)
 ;;=^266994
 ;;^UTILITY(U,$J,358.3,5222,0)
 ;;=155.0^^50^363^24
 ;;^UTILITY(U,$J,358.3,5222,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5222,1,1,0)
 ;;=1^155.0
 ;;^UTILITY(U,$J,358.3,5222,1,2,0)
 ;;=2^LIVER CANCER
 ;;^UTILITY(U,$J,358.3,5222,2)
 ;;=^73526
 ;;^UTILITY(U,$J,358.3,5223,0)
 ;;=200.60^^50^363^26
 ;;^UTILITY(U,$J,358.3,5223,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5223,1,1,0)
 ;;=1^200.60
 ;;^UTILITY(U,$J,358.3,5223,1,2,0)
 ;;=2^LYMPHOMA,ANAPLASTIC LARGE CELL
 ;;^UTILITY(U,$J,358.3,5223,2)
 ;;=^335299
 ;;^UTILITY(U,$J,358.3,5224,0)
 ;;=200.20^^50^363^27
 ;;^UTILITY(U,$J,358.3,5224,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5224,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,5224,1,2,0)
 ;;=2^LYMPHOMA,BURKITT'S
 ;;^UTILITY(U,$J,358.3,5224,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,5225,0)
 ;;=201.90^^50^363^28
 ;;^UTILITY(U,$J,358.3,5225,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5225,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,5225,1,2,0)
 ;;=2^LYMPHOMA,HODGKIN'S
 ;;^UTILITY(U,$J,358.3,5225,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,5226,0)
 ;;=200.70^^50^363^29
 ;;^UTILITY(U,$J,358.3,5226,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5226,1,1,0)
 ;;=1^200.70
 ;;^UTILITY(U,$J,358.3,5226,1,2,0)
 ;;=2^LYMPHOMA,LARGE CELL
 ;;^UTILITY(U,$J,358.3,5226,2)
 ;;=^335300
 ;;^UTILITY(U,$J,358.3,5227,0)
 ;;=200.40^^50^363^30
 ;;^UTILITY(U,$J,358.3,5227,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5227,1,1,0)
 ;;=1^200.40
 ;;^UTILITY(U,$J,358.3,5227,1,2,0)
 ;;=2^LYMPHOMA,MANTLE CELL
 ;;^UTILITY(U,$J,358.3,5227,2)
 ;;=^335297
 ;;^UTILITY(U,$J,358.3,5228,0)
 ;;=200.30^^50^363^31
 ;;^UTILITY(U,$J,358.3,5228,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5228,1,1,0)
 ;;=1^200.30
 ;;^UTILITY(U,$J,358.3,5228,1,2,0)
 ;;=2^LYMPHOMA,MARGINAL ZONE
 ;;^UTILITY(U,$J,358.3,5228,2)
 ;;=^335296
 ;;^UTILITY(U,$J,358.3,5229,0)
 ;;=200.50^^50^363^33
 ;;^UTILITY(U,$J,358.3,5229,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5229,1,1,0)
 ;;=1^200.50
 ;;^UTILITY(U,$J,358.3,5229,1,2,0)
 ;;=2^LYMPHOMA,PRIM CTR NERVOUS SYS
 ;;^UTILITY(U,$J,358.3,5229,2)
 ;;=^335298
 ;;^UTILITY(U,$J,358.3,5230,0)
 ;;=202.90^^50^363^32
 ;;^UTILITY(U,$J,358.3,5230,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5230,1,1,0)
 ;;=1^202.90
 ;;^UTILITY(U,$J,358.3,5230,1,2,0)
 ;;=2^LYMPHOMA,OTHER SITE
 ;;^UTILITY(U,$J,358.3,5230,2)
 ;;=^267504
 ;;^UTILITY(U,$J,358.3,5231,0)
 ;;=200.10^^50^363^34
 ;;^UTILITY(U,$J,358.3,5231,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5231,1,1,0)
 ;;=1^200.10
 ;;^UTILITY(U,$J,358.3,5231,1,2,0)
 ;;=2^LYMPHOSARCOMA
 ;;^UTILITY(U,$J,358.3,5231,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,5232,0)
 ;;=172.9^^50^363^35
 ;;^UTILITY(U,$J,358.3,5232,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5232,1,1,0)
 ;;=1^172.9
 ;;^UTILITY(U,$J,358.3,5232,1,2,0)
 ;;=2^MALIGNANT MELANOMA
 ;;^UTILITY(U,$J,358.3,5232,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,5233,0)
 ;;=199.0^^50^363^37
 ;;^UTILITY(U,$J,358.3,5233,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5233,1,1,0)
 ;;=1^199.0
 ;;^UTILITY(U,$J,358.3,5233,1,2,0)
 ;;=2^METASTATIC CA OF UNKN PRIMARY
 ;;^UTILITY(U,$J,358.3,5233,2)
 ;;=^267340
 ;;^UTILITY(U,$J,358.3,5234,0)
 ;;=203.00^^50^363^38
 ;;^UTILITY(U,$J,358.3,5234,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5234,1,1,0)
 ;;=1^203.00
 ;;^UTILITY(U,$J,358.3,5234,1,2,0)
 ;;=2^MULTIPLE MYELOMA
 ;;^UTILITY(U,$J,358.3,5234,2)
 ;;=^336847
 ;;^UTILITY(U,$J,358.3,5235,0)
 ;;=238.75^^50^363^39
 ;;^UTILITY(U,$J,358.3,5235,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5235,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,5235,1,2,0)
 ;;=2^MYELODYSPLASTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,5235,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,5236,0)
 ;;=157.9^^50^363^41
 ;;^UTILITY(U,$J,358.3,5236,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5236,1,1,0)
 ;;=1^157.9
 ;;^UTILITY(U,$J,358.3,5236,1,2,0)
 ;;=2^PANCREATIC CANCER
 ;;^UTILITY(U,$J,358.3,5236,2)
 ;;=^267103
 ;;^UTILITY(U,$J,358.3,5237,0)
 ;;=187.9^^50^363^42
 ;;^UTILITY(U,$J,358.3,5237,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5237,1,1,0)
 ;;=1^187.9
 ;;^UTILITY(U,$J,358.3,5237,1,2,0)
 ;;=2^PENILE CANCER
 ;;^UTILITY(U,$J,358.3,5237,2)
 ;;=^267252
 ;;^UTILITY(U,$J,358.3,5238,0)
 ;;=149.9^^50^363^43
 ;;^UTILITY(U,$J,358.3,5238,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5238,1,1,0)
 ;;=1^149.9
 ;;^UTILITY(U,$J,358.3,5238,1,2,0)
 ;;=2^PHARYNGEAL CANCER
 ;;^UTILITY(U,$J,358.3,5238,2)
 ;;=^267054
 ;;^UTILITY(U,$J,358.3,5239,0)
 ;;=163.9^^50^363^44
 ;;^UTILITY(U,$J,358.3,5239,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5239,1,1,0)
 ;;=1^163.9
 ;;^UTILITY(U,$J,358.3,5239,1,2,0)
 ;;=2^PLEURAL CANCER
 ;;^UTILITY(U,$J,358.3,5239,2)
 ;;=^267140
 ;;^UTILITY(U,$J,358.3,5240,0)
 ;;=185.^^50^363^45
 ;;^UTILITY(U,$J,358.3,5240,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5240,1,1,0)
 ;;=1^185.
 ;;^UTILITY(U,$J,358.3,5240,1,2,0)
 ;;=2^PROSTATE CANCER
 ;;^UTILITY(U,$J,358.3,5240,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,5241,0)
 ;;=287.9^^50^363^46
 ;;^UTILITY(U,$J,358.3,5241,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5241,1,1,0)
 ;;=1^287.9
 ;;^UTILITY(U,$J,358.3,5241,1,2,0)
 ;;=2^PURPURA/OTH HEMORRHAGIC COND
 ;;^UTILITY(U,$J,358.3,5241,2)
 ;;=^123920
 ;;^UTILITY(U,$J,358.3,5242,0)
 ;;=154.3^^50^363^47
 ;;^UTILITY(U,$J,358.3,5242,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5242,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,5242,1,2,0)
 ;;=2^RECTAL CANCER
 ;;^UTILITY(U,$J,358.3,5242,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,5243,0)
 ;;=189.9^^50^363^62
 ;;^UTILITY(U,$J,358.3,5243,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5243,1,1,0)
 ;;=1^189.9
 ;;^UTILITY(U,$J,358.3,5243,1,2,0)
 ;;=2^URINARY ORGAN CANCER
 ;;^UTILITY(U,$J,358.3,5243,2)
 ;;=^267269
 ;;^UTILITY(U,$J,358.3,5244,0)
 ;;=142.9^^50^363^49
 ;;^UTILITY(U,$J,358.3,5244,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5244,1,1,0)
 ;;=1^142.9
 ;;^UTILITY(U,$J,358.3,5244,1,2,0)
 ;;=2^SALIVARY GLAND CANCER
 ;;^UTILITY(U,$J,358.3,5244,2)
 ;;=^267009
 ;;^UTILITY(U,$J,358.3,5245,0)
 ;;=160.9^^50^363^52
 ;;^UTILITY(U,$J,358.3,5245,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5245,1,1,0)
 ;;=1^160.9
 ;;^UTILITY(U,$J,358.3,5245,1,2,0)
 ;;=2^SINUS,NASAL & MIDDLE EAR CANCER
 ;;^UTILITY(U,$J,358.3,5245,2)
 ;;=^267127
 ;;^UTILITY(U,$J,358.3,5246,0)
 ;;=151.9^^50^363^56
 ;;^UTILITY(U,$J,358.3,5246,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5246,1,1,0)
 ;;=1^151.9
 ;;^UTILITY(U,$J,358.3,5246,1,2,0)
 ;;=2^STOMACH CANCER
 ;;^UTILITY(U,$J,358.3,5246,2)
 ;;=^73532
 ;;^UTILITY(U,$J,358.3,5247,0)
 ;;=186.9^^50^363^57
 ;;^UTILITY(U,$J,358.3,5247,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5247,1,1,0)
 ;;=1^186.9
 ;;^UTILITY(U,$J,358.3,5247,1,2,0)
 ;;=2^TESTICULAR CANCER
 ;;^UTILITY(U,$J,358.3,5247,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,5248,0)
 ;;=164.9^^50^363^59
 ;;^UTILITY(U,$J,358.3,5248,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5248,1,1,0)
 ;;=1^164.9
 ;;^UTILITY(U,$J,358.3,5248,1,2,0)
 ;;=2^THYMUS,HRT & MEDIASTINAL CA
 ;;^UTILITY(U,$J,358.3,5248,2)
 ;;=^267150
 ;;^UTILITY(U,$J,358.3,5249,0)
 ;;=141.9^^50^363^61
 ;;^UTILITY(U,$J,358.3,5249,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5249,1,1,0)
 ;;=1^141.9
 ;;^UTILITY(U,$J,358.3,5249,1,2,0)
 ;;=2^TONGUE CANCER
 ;;^UTILITY(U,$J,358.3,5249,2)
 ;;=^266995
 ;;^UTILITY(U,$J,358.3,5250,0)
 ;;=239.9^^50^363^40
 ;;^UTILITY(U,$J,358.3,5250,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5250,1,1,0)
 ;;=1^239.9
 ;;^UTILITY(U,$J,358.3,5250,1,2,0)
 ;;=2^OTHER CANCER
 ;;^UTILITY(U,$J,358.3,5250,2)
 ;;=^82022
 ;;^UTILITY(U,$J,358.3,5251,0)
 ;;=154.2^^50^363^1
 ;;^UTILITY(U,$J,358.3,5251,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5251,1,1,0)
 ;;=1^154.2
 ;;^UTILITY(U,$J,358.3,5251,1,2,0)
 ;;=2^ANAL CANAL CANCER
 ;;^UTILITY(U,$J,358.3,5251,2)
 ;;=^267091
 ;;^UTILITY(U,$J,358.3,5252,0)
 ;;=154.3^^50^363^2
 ;;^UTILITY(U,$J,358.3,5252,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5252,1,1,0)
 ;;=1^154.3
 ;;^UTILITY(U,$J,358.3,5252,1,2,0)
 ;;=2^ANUS CANCER
 ;;^UTILITY(U,$J,358.3,5252,2)
 ;;=^267092
 ;;^UTILITY(U,$J,358.3,5253,0)
 ;;=164.0^^50^363^58
 ;;^UTILITY(U,$J,358.3,5253,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5253,1,1,0)
 ;;=1^164.0
 ;;^UTILITY(U,$J,358.3,5253,1,2,0)
 ;;=2^THYMUS CANCER
 ;;^UTILITY(U,$J,358.3,5253,2)
 ;;=^267145
 ;;^UTILITY(U,$J,358.3,5254,0)
 ;;=164.1^^50^363^18
 ;;^UTILITY(U,$J,358.3,5254,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5254,1,1,0)
 ;;=1^164.1
 ;;^UTILITY(U,$J,358.3,5254,1,2,0)
 ;;=2^HEART CANCER
 ;;^UTILITY(U,$J,358.3,5254,2)
 ;;=^267146
 ;;^UTILITY(U,$J,358.3,5255,0)
 ;;=164.2^^50^363^36
 ;;^UTILITY(U,$J,358.3,5255,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5255,1,1,0)
 ;;=1^164.2
 ;;^UTILITY(U,$J,358.3,5255,1,2,0)
 ;;=2^MEDIASTINAL CA
 ;;^UTILITY(U,$J,358.3,5255,2)
 ;;=^267147
 ;;^UTILITY(U,$J,358.3,5256,0)
 ;;=173.90^^50^363^53
 ;;^UTILITY(U,$J,358.3,5256,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5256,1,1,0)
 ;;=1^173.90
 ;;^UTILITY(U,$J,358.3,5256,1,2,0)
 ;;=2^SKIN, MALIGNANT SITE UNSP
 ;;^UTILITY(U,$J,358.3,5256,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,5257,0)
 ;;=173.91^^50^363^4
 ;;^UTILITY(U,$J,358.3,5257,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5257,1,1,0)
 ;;=1^173.91
 ;;^UTILITY(U,$J,358.3,5257,1,2,0)
 ;;=2^BCC SKIN, SITE UNSP
 ;;^UTILITY(U,$J,358.3,5257,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,5258,0)
 ;;=173.92^^50^363^51
 ;;^UTILITY(U,$J,358.3,5258,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,5258,1,1,0)
 ;;=1^173.92
